Develops technologies for treating refractory materials in the mining industry. Commercializes the CLEVR process for extracting precious metals. Now — the numbers.
This is an established company with proven profits.
An average decline of 17% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
The gap is $16.5M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 3.3× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: The profit kept from each sale is thin.
An investor who bought at the very peak is down 87% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The net profit margin is 52% — still a thick cushion, though costs have been eating into it lately.
The stock sits at $0.04. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Over the last 4 years, sales fell about 17% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.